Delivery Order SPE2DB22D1106-SPE2DB24FDVA0
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $36,218.78 firm fixed-price delivery order contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,671.99 firm fixed price contract is for the delivery of the HIV medication BIKTARVY 50-200-25 MG TABLET in 30-count packages. This award is a part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award, valued at $17,986.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Biktarvy 50-200-25 mg tablets, a brand-name HIV medication. This is a Firm Fixed Price delivery order contract with a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $29,664.17 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,696.76, is for the delivery of Biktarvy 50-200-25 mg tablets, which are used to treat HIV. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,934.84 firm fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
- This federal contract award, valued at $27,141.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of 4,556,644,517 units of the HIV medication Biktarvy 50-200-25 mg tablet with a completion date of March 23, 2022. The contract was awarded as a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $41,322.09 and is a delivery order for the medication Biktarvy, a combination drug used to treat HIV. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $94,596.71, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty medication used in the treatment of HIV/AIDS. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,018.10, is for the delivery of Biktarvy 50-200-25 mg tablets. The contract is a firm fixed-price Delivery Order with an ultimate completion date of January 26, 2022. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDVA0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $42,598.48, is for the delivery of the HIV medication Biktarvy 50-200-25 MG Tablet. The contract has an ultimate completion date of January 16, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.6k | 1/12/24 |